Muscarinic receptor subtypes mediate vasorelaxation in isolated horse deep dorsal penile vein

Urology

Volumn 62, Issue 2, 2003, Pages 357-361

  Martínez, Ana Cristina ^a   Hernández, Medardo ^a   Rivera, Luis ^a   Recio, Paz ^a   García Sacristán, Albino ^a   Benedito, Sara ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ATROPINE; CARBACHOL; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PARA FLUOROHEXAHYDROSILADIFENIDOL; PIRENZEPINE; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; EVOKED MUSCLE RESPONSE; HORSE; INHIBITION KINETICS; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PENILE BLOOD VESSEL; PENIS ERECTION; PRIORITY JOURNAL; VASODILATATION; VEIN; VENOCONSTRICTION;

EID: 0043125482     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00253-X     Document Type: Article

References (30)

1. Moreland R.B., Hsieh G., Nakane M., et al. The biochemical and neurologic basis for the treatment of male erectile dysfunction. J Pharmacol Exp Ther. 296:2001;225-234.
2. Andersson K.E., Wagner G. Physiology of penile erection. Physiol Rev. 75:1995;191-236.
3. Fournier G.R., Juenemann K.-P., Lue T.F., et al. Mechanisms of venous occlusion during canine penile erection an anatomic demonstration . J Urol. 137:1987;163-167.
4. Juenemann K.-P., Luo J.-A., Lue T.F., et al. Further evidence of venous outflow restriction during erection. Br J Urol. 58:1986;320-324.
5. Kirkeby H.J., Jorgensen J.C., Ottesen B. Neuropeptide Y (NPY) in human penile corpus cavernosum tissue and circumflex veins occurrence and in vitro effects . J Urol. 145:1991;605-609.
6. Segarra G., Medina P., Domenech C., et al. Neurogenic contraction and relaxation of human penile deep dorsal vein. Br J Pharmacol. 124:1998;788-794.
7. Segarra G., Medina P., Acuña A., et al. Comparative effects of dilator drugs on human penile dorsal artery and deep dorsal vein. Clin Sci. 96:1999;59-65.
8. Martínez A.C., Prieto D., Raposo R., et al. Endothelium-independent relaxation induced by histamine in human dorsal penile artery. Clin Exp Pharmacol Physiol. 27:2000;500-507.
9. Martínez A.C., García-Sacristán A., Rivera L., et al. Biphasic response to histamine in rabbit penile dorsal artery. J Cardiovasc Pharmacol. 36:2000;737-743.
10. Martínez A.C., Rivera L., Raposo R., et al. Evidence of histamine receptor function in isolated horse penile dorsal arteries. Life Sci. 67:2000;1355-1368.
11. Martínez A.C., Prieto D., Hernández M., et al. Contractile response of horse deep dorsal penile vein to histamine. Int J Impot Res. 14:2002;85-92.
12. Recio P., López P.G., Fernández J.L.G., et al. Pharmacological characterization of adrenoceptors in horse corpus cavernosum penis. J Auton Pharmacol. 17:1997;199-206.
13. Andersson K.E. Pharmacology of penile erection. Pharmacol Rev. 53:2001;417-450.
14. Traish A.M., Palmer M.S., Goldstein I., et al. Expression of functional muscarinic acetylcholine receptor subtypes in human corpus cavernosum and in cultured smooth muscle cells. Receptor. 5:1995;159-176.
15. Nehra A., Barrett D.M., Moreland R.B. Pharmacotherapeutic advances in the treatment of erectile dysfunction. Mayo Clin Proc. 74:1999;709-722.
16. Simonsen U., Prieto D., Hernández M., et al. Prejunctional alpha 2-adrenoceptors inhibit nitrergic neurotransmission in horse penile resistance arteries. J Urol. 157:1997;2356-2360.
17. Simonsen U., Prieto D., Hernández M., et al. Adrenoceptor-mediated regulation of the contractility in horse penile resistance arteries. J Vasc Res. 34:1997;90-102.
18. + channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries. Br J Pharmacol. 123:1998;1609-1620.
19. Högestätt E.D., Andersson K.-E., Edvinsson L. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand. 117:1983;49-61.
20. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonism. Br J Pharmacol. 14:1959;48-58.
21. Tallarida R.J., Murray R.B. Manual of Pharmacologic Calculations with Computer Programs. 1984;30 Springer-Verlag, New York.
22. 3 muscarinic receptors in human pulmonary arteries. Br J Pharmacol. 119:1996;149-157.
23. 1 muscarinic receptor on the endothelium of human pulmonary veins. Br J Pharmacol. 130:2000;73-78.
24. Caulfield M.P., Birdsall N.J.M. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 50:1998;279-288.
25. Eglen R.M., Choppin A., Dillon M.P., et al. Muscarinic receptor ligands and their therapeutic potential. Curr Opin Chem Biol. 3:1999;426-432.
26. Eglen R.M., Hegde S., Watson N.V. Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev. 48:1996;531-565.
27. Obi T., Kabeyama A., Nishio A. Characterization of muscarinic receptor subtype mediating contraction and relaxation in equine coronary artery in vitro. J Vet Pharmacol. 17:1995;226-231.
28. Sawyer B.D., Bymaster F.P., Calligaro D.O., et al. Direct pharmacological comparison of the muscarinic receptors mediating relaxation and contraction in the rabbit thoracic aorta. Gen Pharmacol. 32:1999;445-452.
29. Choy W.Y., Wong Y.F., Kwan Y.W., et al. Role of mitogen-activated protein kinase pathway in acetylcholine-mediated in vitro relaxation of rat pulmonary artery. Eur J Pharmacol. 434:2002;55-64.
30. Lue T.F. Physiology of erection and pathophysiology of impotence. Walsh P.C., Gittes R.F., Perlmutter A.D., et al. Campbell's Urology. 1992;709-728 WB Saunders, Philadelphia.